Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

5.6K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cornea Classic: Gomes, Tan, Rapuano et al, "Global Consensus on Keratoconus and Ectatic Diseases" (2015).

Cornea·2026
Same author

Response Letter to the Editor "Refining Impostor Syndrome Measurement in Female Physicians: A Critical Commentary".

Journal of general internal medicine·2026
Same author

Vision in the margins: the association between census tract neighbourhood disadvantage and visual difficulty and blindness in the United States.

Eye (London, England)·2026
Same author

Distinguishing Factors for Microbial Keratitis Groups: A Cross-Sectional Survey of US Cornea Specialists.

Cornea·2026
Same author

Early Treatment Response and 90-Day Vision in Microbial Keratitis.

JAMA ophthalmology·2026
Same author

CHARACTERIZING INTRAOCULAR LENS POSITION, STABILITY, AND IRIS MOBILITY IN EYES THAT HAVE UNDERGONE SUTURELESS INTRASCLERAL HAPTIC FIXATION.

Retina (Philadelphia, Pa.)·2026

Related Experiment Video

Updated: May 28, 2025

Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings
04:00

Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings

Published on: August 2, 2024

1.6K

Factors Associated with Vision Outcomes in Microbial Keratitis: A Multisite Prospective Cohort Study.

Maria A Woodward1, Emily L Vogt2, Leslie M Niziol2

  • 1Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan.

Ophthalmology
|February 10, 2025
PubMed
Summary

Microbial keratitis (MK) patients with poorer initial vision, delayed presentation, and larger infiltrates face worse 90-day vision outcomes. Improving care access and reducing delays are crucial for better vision in MK patients.

Keywords:
Corneal ulcerMicrobial keratitisPrognosisVision impairmentVision outcomes

More Related Videos

Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis
07:24

Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis

Published on: February 6, 2021

11.2K
Conjunctival Commensal Isolation and Identification in Mice
07:52

Conjunctival Commensal Isolation and Identification in Mice

Published on: May 1, 2021

4.3K

Related Experiment Videos

Last Updated: May 28, 2025

Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings
04:00

Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings

Published on: August 2, 2024

1.6K
Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis
07:24

Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis

Published on: February 6, 2021

11.2K
Conjunctival Commensal Isolation and Identification in Mice
07:52

Conjunctival Commensal Isolation and Identification in Mice

Published on: May 1, 2021

4.3K

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Public Health

Background:

  • Microbial keratitis (MK) is a significant cause of vision loss worldwide.
  • Understanding factors influencing visual outcomes in MK is critical for effective management.
  • This study investigates predictors of 90-day vision in a diverse MK patient cohort.

Purpose of the Study:

  • To identify factors associated with 90-day best-corrected visual acuity (BCVA) in patients with microbial keratitis.
  • To compare these factors between patients in the United States and India.

Main Methods:

  • A multicenter prospective cohort study involving 479 patients with MK across the US and India.
  • Data collected included sociodemographics, clinical measures, and BCVA (logarithm of the minimum angle of resolution units) at baseline and 90 days.
  • Site-stratified multivariable linear regression models were used to analyze associations with 90-day BCVA.

Main Results:

  • Average 90-day BCVA was 1.36 logMAR in the US and 0.70 logMAR in India.
  • In the US, worse 90-day BCVA was linked to worse presenting BCVA, longer presentation delays, no contact lens use, and larger infiltrate size.
  • In India, worse outcomes were associated with worse presenting BCVA, longer delays, diabetes, hypopyon, no recent ocular trauma, and larger infiltrate size.

Conclusions:

  • Initial visual acuity, time to presentation, and stromal infiltrate size are key predictors of 90-day vision outcomes in MK.
  • Specific risk factors varied between the US and India, highlighting the need for tailored interventions.
  • Implementing systems to reduce care delays and improve access is essential for enhancing vision outcomes in MK patients.